Receiving a diagnosis of blood cancer can make you feel as if your life has gone into darkness and all your plans have been put on hold. Suddenly, your focus in life becomes treating your condition and getting well. In this article, we will tell you about "Bdbrut 140 mg capsule" - one of the highly effective drugs used to treat adults with certain types of leukemias and lymphomas. Leukemia and Lymphoma are both forms of blood cancer. The main difference is that leukemia affects the blood and bone marrow, while lymphomas tend to affect the lymph nodes.
- Mar 29 Tue 2022 19:15
- Jan 20 Thu 2022 15:44
Chronic Idiopathic Thrombocytopenic Purpura - a loss in the platelet of the body and the continuous reduction in platelet count. Eltrombopag, a thrombopoietin receptor agonist helps in the stimulation of platelet production. It is an orally administered medicine available in the medical industry by different brand names. The international brand name is "Promacta".
In ITP, continuous low platelet counts can increase the risk of serious bleeding (intracranial hemorrhage). Eltrombopag - selectively binds to the transmembrane domain of the thrombopoietin receptor on the surface of platelets, which results in maintaining platelet counts, with the least possible intervention, at levels that prevent bleeding, thereby stimulating the formation of new platelets.
- Dec 31 Fri 2021 17:23
If you've been diagnosed with prostate cancer or have a family member or friend who is dealing with prostate cancer, you're not alone. Prostate cancer, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline, according to new research. One of the major treatments for this deadly disease is "Bdenza 40 mg Capsule". It is used to treat advanced-stage prostate cancer when surgery or other medicines have not worked or have stopped working.
- Dec 21 Tue 2021 19:00
Sorafenib is one of the effective anti-cancer medicine which is used to treat certain types of Hepatocellular carcinoma (HCC, a type of liver cancer), Renal cell carcinoma (RCC, a type of kidney cancer), and Differentiated thyroid carcinoma (DTC, a type of thyroid cancer). Cancer cells contain proteins that encourage them to grow, and this drug (Tyrosine Kinase inhibitor) targets those proteins. Tumors also need to form new blood vessels to grow, and sorafenib blocks this action.
- Dec 07 Tue 2021 15:17
- Dec 01 Wed 2021 17:24
- Nov 29 Mon 2021 14:35